Excalipoint Therapetics is based in Shanghai, China. It has raised $69M in total funding. Latest round: Seed.
Excalipoint Therapetics funding overview
Excalipoint Therapetics is based in Shanghai, China. Excalipoint Therapetics has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in March 2026. The round record for Excalipoint Therapetics runs through 2026; nothing later has been disclosed. Investors on record include HSG, Apricot Capital, Yuanbio Venture Capital, 5Y Capital, Co-Win Ventures, Med-Fine Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Frequently asked about Excalipoint Therapetics funding
How much has Excalipoint Therapetics raised?
Excalipoint Therapetics has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Excalipoint Therapetics?
HSG, Apricot Capital, Yuanbio Venture Capital, 5Y Capital, Co-Win Ventures, Med-Fine Capital are named among the investors backing Excalipoint Therapetics.
What was the latest Excalipoint Therapetics funding round?
The most recent disclosed round is a Seed, announced in March 2026.
Where is Excalipoint Therapetics based?
Excalipoint Therapetics is based in Shanghai, China.
When did Excalipoint Therapetics last raise?
The last disclosed Excalipoint Therapetics round closed in March 2026 at Seed.
Every Excalipoint Therapetics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
